GGrantIndex
Sort

53,477 grants matching addiction

Significance of Protein Synthesis by the Integrated Stress Response in Neuromodulatory Neurons for Adaptive Behavior and Synaptic Plasticity

$636,300
Nicole Calakos · Duke University · R01 · FY2023 · NS

Impact of Marijuana Legalization on Opioid Prescribing and Poisonings in Colorado

$636,198
Rosalie Pacula · Rand Corporation · R01 · FY2018 · DA

Effects of Opiate on Virus/Host Responses in SHIV/Macaques

$636,187
Anil Kumar · University Of Missouri Kansas City · R01 · FY2009 · DA

Lineage Addiction in Prostate Cancer: Molecular Interactions and Translational Biomarkers

$636,167
Joshua Michael Lang · University Of Wisconsin-Madison · P01 · FY2025 · CA

Effect of methadone on the developmental properties of human brain organoids

$636,157
Gabriel G Haddad · University Of California, San Diego · R01 · FY2024 · DA

Effect of Bariatric Surgery on Insulin Resistance & CVD

$636,129
Anita P Courcoulas · University Of Pittsburgh At Pittsburgh · U01 · FY2009 · DK

Multiscale Genetic Connectivity of Primate Social Circuits

$636,124
Julie R Korenberg · University Of Utah · R01 · FY2017 · MH

Biomarkers of lung cancer risk

$636,123
Paul Joseph Brennan · Baylor College Of Medicine · U19 · FY2019 · CA

Neurobiological Consequences of Long-Term Opioid Therapy in the Brain and Spinal Cord

$636,122
Katherine Theresa Martucci · Duke University · R01 · FY2024 · DA

Testing a Promising Treatment for Youth Substance Abuse in a Community Setting

$636,114
Scott W Henggeler · Medical University Of South Carolina · R01 · FY2015 · DA

Functional and Genomic Signatures of Escalated Fentanyl Use

$636,073
Jill R. Turner · University Of Kentucky · R01 · FY2025 · DA

Potent and Highly Selective D3 Ligands for the Treatment of Cocaine Abuse

$635,945
Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2013 · DA

HIV Disease Outcomes in Drug Users in Clinical Practice

$635,932
Richard Douglas Moore · Johns Hopkins University · R01 · FY2013 · DA

Zonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuroclinical Assessment Framework

$635,863
Sterling M McPherson · Washington State University · R01 · FY2021 · AA

Zonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuroclinical Assessment Framework

$635,863
Sterling M McPherson · Washington State University · R01 · FY2023 · AA

Zonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuroclinical Assessment Framework

$635,863
Sterling M McPherson · Washington State University · R01 · FY2022 · AA

Exercise in Methamphetamine Use Disorder: Dopamine Receptor Upregulation and Neural Function

$635,862
Edythe D London · University Of California Los Angeles · R01 · FY2022 · DA

Mindfulness-based Smoking Cessation Enhanced with Mobile Technology for Low-Income Smokers

$635,853
Claire Adams Spears · Georgia State University · R01 · FY2019 · CA

Alcohol Stimulation and Sedation in Binge Drinkers - Renewal 01

$635,722
Andrea C King · University Of Chicago · R01 · FY2020 · AA

UCSF-Kaiser Department of Research Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) Program

$635,658
Claire D. Brindis · University Of California, San Francisco · K12 · FY2020 · HD

Contingency Management Treatment of Alcohol Abuse American Indian People

$635,604
Michael G McDonell · Washington State University · R01 · FY2015 · AA

Motivation in Context: Risk for escalation of substance use

$635,542
Craig R Colder · State University Of New York At Buffalo · R01 · FY2016 · DA

Administrative Core

$635,541
Jasjit S Ahluwalia · Brown University · P20 · FY2025 · GM

SPINE-WORK: An inclusive research community to study and improve force-based manipulations for spine pain

$635,443
Beth A Winkelstein · University Of Pennsylvania · U24 · FY2025 · AT

Clinical Laboratory Core

$635,387
Jennifer W Tidey · Brown University · P20 · FY2022 · GM